Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain
about
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsMediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.EBNA2 and activated Notch induce expression of BATFProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structureExtensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesHairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells.EBNA-LP associates with cellular proteins including DNA-PK and HA95.Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-associationDirect and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylationEpstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.Evolutionary aspects of oncogenic herpesvirusesThe expression and function of Epstein-Barr virus encoded latent genesMolecular virology of Epstein-Barr virus.Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.Epstein-barr virus-induced changes in B-lymphocyte gene expression.Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activationEpstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growthInduction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell FactorMitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.Four EBNA2 domains are important for EBNALP coactivationInduction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli.Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.
P2860
Q22254088-59365194-CD02-41F9-9284-97CB28DE7ACDQ24336304-6C152E98-E427-4AA5-A960-87C5700DB853Q24540313-4AF646F6-07D0-4E34-97F9-B8DFCF75ADC6Q24679432-89949D6A-CB7B-4D99-A0CE-888194C4FE86Q28114910-C3448693-1710-4654-8E46-7F79C31973BAQ30939262-0976E8E0-D2EA-4564-A946-F4171AE16F24Q30981859-1A679BDE-5F0C-416F-BCAC-B68F38C2A5DDQ33643991-75420050-F916-487F-BBF2-3B16E0CCEFDCQ33749934-43F21766-3F78-4919-AE81-14ACB5DB82C8Q33754919-90EA6BCA-86D2-4357-9092-AC1AF273F2A9Q33786088-72F76191-3ACE-499D-8A5F-E2E3FCB6968DQ33787090-28560C84-B199-44D7-833D-88E53036949EQ33795078-F007B91B-4149-46A0-B1EB-22F2D4630710Q33809963-A2974E7C-1E57-4348-B9FB-61E2F4DFBBA6Q33850400-889E1E7D-BBC7-47AB-A307-F9ED8CC5DD96Q33850943-4674C5A2-2C85-4E5C-8863-ED4E8D1F3E37Q33850964-59759124-AA8C-4C72-9DC9-1A7BD1B37AF4Q33851043-2BECD723-2A29-42EE-8F1C-8A069A46E660Q33851767-776DBCFF-9C93-4FD8-9F94-60EAAE5EF9C0Q33911878-7FAF20E4-8E8A-45C6-B21B-487B61D3B4A4Q33918592-FDD1CA74-6F2F-4680-A15C-2A242D52DF81Q33998709-C220C445-7F20-4775-B00B-FB382404FA4DQ34089478-D51F9408-8078-473C-8F30-066E1C5A18EDQ34089485-2BD4B364-880B-40D6-9BE9-32DD7E99FFEDQ34225554-86515BA9-DD7E-41E0-9133-A5FAC8E7D8ACQ34334212-31C054BC-52C2-4861-9EA1-974FD7D6FC2CQ34347958-8BF4DC33-2BD0-4DD5-A495-9525BF09D831Q34998243-B79C8CA9-CA83-4659-AF9B-E6047FEBC893Q35531692-28600C24-5B8D-4FB2-A078-CFFFCCDBE4E8Q35732134-A593F348-A363-4071-9533-9160B05610F0Q35839875-DFDAC208-64F1-41EF-BFAC-F72306B24AC5Q35891360-48545C3F-C07C-4652-9414-D4AA86EEB2E0Q36525145-3E7AEB09-6569-4079-BA08-9FC12404FE1BQ36736410-1E58172E-D7D3-4B2F-99C5-DF37EAA2E536Q37009375-862C3C1D-4468-4E2F-8E0A-A062E25A3DF5Q37093792-E3A7E7A5-3B68-4FA8-B10B-B5F6B23DE0D4Q37567915-62FE32D2-E5B8-402A-B995-BC4299809832Q37596540-0F143667-0EE9-4985-BEBC-13C2B182EC45Q37596895-BB7F16C9-5B8E-4458-9AB1-CCFD92273E1AQ38289967-C16D38EA-532E-40B3-B188-124317D3C714
P2860
Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@ast
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@en
type
label
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@ast
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@en
prefLabel
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@ast
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus leader prot ...... ole for the W1W2 repeat domain
@en
P2093
P2860
P304
P407
P577
1997-09-01T00:00:00Z